| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |